![Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis | Respiratory Research | Full Text Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-022-02079-6/MediaObjects/12931_2022_2079_Fig1_HTML.png)
Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis | Respiratory Research | Full Text
Integration of TB-LAM and Xpert MTB/RIF (Xpert) testing to improve TB case detection and shorten time to treatment initiation among People Living with HIV (PLHIV) in Harare City, Zimbabwe
![4.2 Algorithm 2 – LF-LAM testing to aid in the diagnosis of TB among People with HIV | TB Knowledge Sharing 4.2 Algorithm 2 – LF-LAM testing to aid in the diagnosis of TB among People with HIV | TB Knowledge Sharing](https://tbksp.org/sites/default/files/inline-images/Fig4-3.gif)
4.2 Algorithm 2 – LF-LAM testing to aid in the diagnosis of TB among People with HIV | TB Knowledge Sharing
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis
![Lymphangioleiomyomatosis (LAM) Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research Lymphangioleiomyomatosis (LAM) Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research](https://www.databridgemarketresearch.com/media/2021/7/995271e8-5ddf-4417-bf6d-a7f6b9db1b37.jpg)
Lymphangioleiomyomatosis (LAM) Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research
![IJERPH | Free Full-Text | Decision Analytic Modeling for Global Clinical Trial Planning: A Case for HIV-Positive Patients at High Risk for Mycobacterium tuberculosis Sepsis in Uganda IJERPH | Free Full-Text | Decision Analytic Modeling for Global Clinical Trial Planning: A Case for HIV-Positive Patients at High Risk for Mycobacterium tuberculosis Sepsis in Uganda](https://www.mdpi.com/ijerph/ijerph-20-05041/article_deploy/html/images/ijerph-20-05041-g001-550.jpg)
IJERPH | Free Full-Text | Decision Analytic Modeling for Global Clinical Trial Planning: A Case for HIV-Positive Patients at High Risk for Mycobacterium tuberculosis Sepsis in Uganda
![Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases | European Respiratory Society Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases | European Respiratory Society](https://erj.ersjournals.com/sites/default/files/highwire/erj/43/4.cover-source.jpg)
Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases | European Respiratory Society
![4.2.1 Decision pathway for Algorithm 2 – LF-LAM testing to aid in the diagnosis of TB among People with HIV | TB Knowledge Sharing 4.2.1 Decision pathway for Algorithm 2 – LF-LAM testing to aid in the diagnosis of TB among People with HIV | TB Knowledge Sharing](https://tbksp.org/sites/default/files/inline-images/2b-B-LF-LAM-testing-to-aid-in-the-diagnosis-of-TB.gif)
4.2.1 Decision pathway for Algorithm 2 – LF-LAM testing to aid in the diagnosis of TB among People with HIV | TB Knowledge Sharing
![Sthanu on X: "@BrownHospMed @Radiopaedia Lymphangioleiomyomatosis an indolent, progressive growth of smooth muscle cells throughout the lungs, pulmonary blood vessels, lymphatics, and pleurae occurs in young women Treatment is with sirolimus or Sthanu on X: "@BrownHospMed @Radiopaedia Lymphangioleiomyomatosis an indolent, progressive growth of smooth muscle cells throughout the lungs, pulmonary blood vessels, lymphatics, and pleurae occurs in young women Treatment is with sirolimus or](https://pbs.twimg.com/media/FkMsFIcUoAEbCV7.jpg:large)
Sthanu on X: "@BrownHospMed @Radiopaedia Lymphangioleiomyomatosis an indolent, progressive growth of smooth muscle cells throughout the lungs, pulmonary blood vessels, lymphatics, and pleurae occurs in young women Treatment is with sirolimus or
![Pulmonary Insights | First FDA-Approved Treatment for LAM Spearheaded by UC Research | Pulmonary Insights Pulmonary Insights | First FDA-Approved Treatment for LAM Spearheaded by UC Research | Pulmonary Insights](https://www.uchealth.com/wp-content/uploads/sites/39/2015/08/Frank-McCormack-Photo-for-Becca.jpg)
Pulmonary Insights | First FDA-Approved Treatment for LAM Spearheaded by UC Research | Pulmonary Insights
American Thoracic Society - Lymphangioleiomyomatosis (LAM) is a progressive lung disease that usually strikes women during their childbearing years. Symptoms may include shortness of breath, collapsed lung, chest pain, cough, fatigue and
![Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients - International Journal of Infectious Diseases Utility of urine lipoarabinomannan (LAM) in diagnosing mycobacteria infection among hospitalized HIV-positive patients - International Journal of Infectious Diseases](https://www.ijidonline.com/cms/asset/03409444-51b7-4579-a07b-f7d47dc9a09d/gr1.jpg)